Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Cannabis sativa oil, also known as hemp oil or CBD oil (when rich in cannabidiol), has been increasingly explored for supporting cancer treatment, particularly in reducing side effects such as pain, nausea, vomiting, and loss of appetite associated with chemotherapy and radiotherapy. The scientific evidence for its effectiveness is limited but growing. Several small clinical studies and systematic reviews suggest that certain cannabinoids—primarily THC and CBD—may help in the management of chemotherapy-induced nausea and vomiting (CINV), especially in cases where conventional antiemetic drugs are insufficient. Some patients also report improvements in appetite and pain relief, though robust clinical trial data are lacking.

The U.S. Food and Drug Administration (FDA) has approved synthetic cannabinoids like dronabinol and nabilone for CINV, indicating some official recognition of their utility. However, these are not the same as over-the-counter cannabis sativa oil, which varies in cannabinoid content and quality. The evidence for CBD oil specifically is less well-established, with most supporting data coming from anecdotal reports, small pilot studies, and animal research. Importantly, there is currently no credible evidence that cannabis sativa oil directly treats cancer or improves survival. Most guidelines recommend its use as an adjunct for symptom management rather than as a primary treatment.

In summary, while there is some scientific basis for using cannabinoids to reduce certain side effects of cancer treatments, the strength of the evidence is moderate at best, and more high-quality research is needed to clarify efficacy, safety, and optimal dosing.

More about Cannabis sativa oil
More about Cancer Treatment (reducing side effects)

Other ingredients used for Cancer Treatment (reducing side effects)

Other health conditions supported by Cannabis sativa oil

Products containing Cannabis sativa oil

Pure Encapsulations Hemp extract VESIsorb®